Bain Capital-backed CitiusTech exploring acquisitions, to evaluate IPO
'It is very much in our growth path," Kohli said, referring to the company's plan to list on the exchanges. 'We will evaluate [it] this year if the markets are good," he said, adding that the company will evaluate listing in either India or the US.
The firm's primary market is the US, accounting for 95% of its revenues. Its investors are Bain Capital Private Equity and EQT Private Capital Asia (previously Baring Private Equity Asia).
Also read: FPI Tracker: Telecom, services, capital goods corner major chunk of inflows; IT, healthcare face heavy selling in May
In 2022, Bloomberg reported, citing people in the know, that CitiusTech had filed confidentially for a US IPO.
The health tech firm is planning expansions in Europe and Japan, as demand for healthcare technology services increases among medtech, healthcare, and life sciences companies.
Kohli said that the firm's specialised focus on healthcare gives it an edge over large Indian IT service companies that cater to various industries. A few other Indian companies are focused solely on healthcare tech services, like IKS Health, which was listed on the exchanges in December 2024 and posted ₹2,664 crore revenue in FY25.
Acquisitions drive growth
The firm is looking at acquisitions this year to drive growth.
'We didn't make any acquisitions for the last two years because the valuation was not great in the market," Kohli said, adding that this year the company is targeting two acquisitions, provided it finds targets that meet its requirements.
CitiusTech is exploring acquisition options which would strengthen its foray into Europe as well as enhance its abilities in the healthcare provider market.
Also read: Jainik Power and Cables IPO allotment to be out soon: Here are steps to check status online and GMP
The company had previously stated a target of $1 billion in revenue by FY28, which it is still aiming for, Kohli said.
'On an organic basis, we continue to grow as per plan," he said.
The company is expecting mid-teens revenue growth in FY26, after high single-digit revenue growth in FY25, Kohli said.
While it hasn't yet posted its FY25 results, it clocked revenue of ₹3,536 crore and a profit of ₹350 crore in FY24.
GenAI tailwind
Kohli sees GenAI as a significant tailwind driving growth, as companies look for cost optimisation solutions. '...today, 25% of our clients give us the opportunity to use GenAI tools. I think in one or two years, 80-100% of our clients will allow GenAI-produced code into their environment," he said.
Also read: Aten Papers & Foam IPO Day 1: Check subscription status, GMP, and other details
Being a healthcare-focused service provider gives CitiusTech an edge as well, according to Kohli. 'It is a huge advantage being just focused on healthcare because a lot of our clients buy us because of our specialised capabilities. All our investment, all our R&D, all our training goes into healthcare only," he said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
31 minutes ago
- Mint
India makes a push for cheaper foreign loans in yen, rupee
India is pressing multilateral development banks (MDBs) to lend more in Japanese yen and Indian rupees in an attempt to reduce borrowing costs and manage exchange rate risks more effectively, two officials aware of the matter said. New Delhi has steadily expanded loans and official development assistance (ODA) in yen to gain from ultra-low interest rates and the rupee's appreciation against the Japanese currency. Many of these loans finance infrastructure and development projects. 'Yen rates remain close to zero, and with the rupee having appreciated significantly against the yen since early 2023, yen borrowings, including through Samurai bonds, have emerged as a compelling option," one of the two officials cited above said, requesting anonymity. Samurai bonds are yen-denominated bonds issued in Japan by foreign entities to raise money. The development assumes significance since MDBs such as the World Bank, Asian Development Bank (ADB) and the International Monetary Fund (IMF) play a central role in global finance, especially in developing economies. These institutions lend in dollar as well as other reserve currencies. ADB, which mainly lends in dollars, has also issued rupee bonds. The Asian Infrastructure Investment Bank (AIIB) too lends in yen, euro and rupees. The yen is part of IMF's special drawing rights (SDR) basket of currencies, and can be used depending on borrower preference and availability. India is pushing for loans in yen, the second official confirmed, adding "These loans and ODAs are not free, and we pay interest on them. A lot has changed now with India's rise at the global high table, and we are in a better position to negotiate our terms and conditions with the MDBs," said the second person. 'Also, given our past record, India also happens to be very attractive for these lending institutions as well, given our repayment history and the credit profile. We will follow the strategy which is in our best interest," the person added. An ADB spokesperson said the bank has received a handful of requests from India for yen-denominated loans in the last two years, with three such agreements signed in 2023 and 2024. These include the Delhi-Meerut RRTS Tranche 3 (2023), the Nagpur Metro Urban Mobility Project (2024) and the Amaravati Capital City Development Programme (2024). The ADB spokesperson pointed out that despite the rising interest in yen loans, 20 out of 22 sovereign loans signed by ADB in India in 2024 were in dollars. 'ADB's advice to borrowers is to choose the most financially advantageous termsbased on needs and risk exposure of the project and the borrower's overall external debt portfolio," the spokesperson added. Queries emailed to the spokespersons of India's finance ministry, World Bank, AIIB, IMF and Exim Bank remained unanswered. 'India is expected to expand its yen exposure further as part of a calibrated shift to longer-tenure, lower-cost financing to mitigate exchange rate risks. It will also explore greater use of the domestic currency. However, the dollar will remain dominant in the medium term, given its role as the principal global reserve currency," the official cited earlier said. According to the Reserve Bank of India (RBI) data, yen-denominated liabilities rose to 6.2% of India's total external debt at the end of March 2025, up from 5.8% a year earlier. In absolute terms, this equals $45.6 billion out of the total $736.3 billion in external debt at the end of FY25. India's total external debt rose 10% in FY25. The US dollar still dominated India's external borrowings, accounting for 54.2%, followed by the Indian rupee (31.1%), yen (6.2%), SDR (4.6%), and the euro (3.2%). While the appeal of yen financing is clear, economists caution that since India lacks a deep forex market for the yen, most conversions still happen through cross-rates with the dollar or euro rather than direct market-determined rates, adding layers of complexity. 'Rupee-denominated loans are preferable from a stability standpoint. As for yen borrowings, unless a more efficient and transparent yen market develops, the advantages remain limited. In many cases, dollar- or SDR-denominated loans might still be more practical," said Bhanumurthy N.R., director of the Madras School of Economics. India's yen borrowing strategy is gaining traction across both bilateral and multilateral channels. In FY24 alone, India signed yen loan agreements with the Japan International Cooperation Agency (JICA) worth over ¥276 billion (around ₹15,600 crore), funding metro rail, logistics, and renewable energy projects. In FY25, JICA followed up with six ODA agreements worth ¥191.7 billion ( ₹11,181 crore) to support urban transport, water infrastructure, environmental protection, and livelihood programmes, including Delhi Metro Phase IV, Chennai's desalination plant, biodiversity projects in Punjab, and an aquaculture initiative in Assam. A separate ¥84.3 billion loan for Mumbai Metro Line 3 took the year's total to ¥276 billion ( ₹15,655 crore). 'India's push to secure more yen- and rupee-denominated loans from MDBs reflects a prudent effort to lower external borrowing costs while reducing exposure to the volatility of major foreign currencies like the US dollar," said Venkatakrishnan Srinivasan, managing partner at Rockfort Fincap Llp, a financial advisory firm. 'From a bond market and risk perspective, rupee-denominated MDB funding is a strong fit. It eliminates currency mismatch, enhances debt predictability, and aligns well with India's broader strategy of deepening its local currency bond ecosystem. Yen-denominated loans, though historically low-cost, now come with added complexity due to heightened forex volatility and an uncertain interest rate trajectory in Japan," he added.
Time of India
31 minutes ago
- Time of India
Gujarat hospitals see worrying resistance to powerful antibiotics
SLUG: STATE's AMR PROFILE Ahmedabad: A recent govt study has revealed a worrying trend in Gujarat's hospitals — some of the most powerful antibiotics are no longer effective against common bacterial infections. The report found that more than 40% of E. coli and Klebsiella bacteria — two major antimicrobial-resistant (AMR) pathogens often responsible for serious infections — are now resistant to carbapenems, a high-end antibiotic typically used when all others fail. You Can Also Check: Ahmedabad AQI | Weather in Ahmedabad | Bank Holidays in Ahmedabad | Public Holidays in Ahmedabad This is one of the key findings of the surveillance report by the Gujarat State Antimicrobial Resistance Surveillance Network (GUJSAR), released on Wednesday. The report analysed 14,685 AMR isolates collected between July 1 and December 31, 2024, from 22 network laboratories, including microbiology labs of six govt medical colleges, 13 GMERS medical colleges, and three municipal corporation-run medical colleges. "While other drugs are still available — including colistin, the last resort for very severe bacterial infections — resistance to carbapenems signals that we are rapidly running out of feasible antibiotic options for serious infections. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 今すぐ、2025年最高のRPGゲームを制覇しよう！ BuzzDaily Winners ゲームをプレイ Undo Switching to a higher class of antibiotics also brings short-term and long-term side effects," said a senior city-based microbiologist. A senior state health department official told TOI that Gujarat is among the few Indian states with a dedicated AMR surveillance network. "All steps — from identifying antimicrobial resistance to specific antibiotics to reporting isolates — are standardized," the official said. T he report focuses on priority pathogens, identified by the World Health Organization (WHO) as posing the highest threat to human health due to their resistance to existing antibiotics. The findings show that the majority of AMR isolates were from urine samples (42%), followed by pus aspirates (31%). About 62% of the isolates came from hospitalized patients, and 16% from patients in intensive care units (ICUs). Sources said that AMR organisms have been rising steadily — a trend also highlighted in Indian Council of Medical Research (ICMR) reports. "In recent years, gram-negative bacteria have shown increased resistance to several commonly used antibiotics. Some bacteria isolated from blood cultures also showed resistance, suggesting that if the correct antibiotics are not administered in time, it can lead to septicaemia — a potentially life-threatening bloodstream infection," said a microbiologist.
Time of India
an hour ago
- Time of India
Kolhapuri chappal gets leg-up over ‘copying' by Italian brand
Mumbai: A public interest litigation filed in Bombay high court seeks reliefs against Italian luxury fashion label Prada after it showcased open-toe leather sandals at the recent Milan Fashion Week that are "deceptively similar" to the Kolhapuri chappal. "The Kolhapuri chappal is the cultural symbol of Maharashtra and has special public sentiments attached to it. The act of copying and misrepresenting this craft in international markets effectively amounts to depriving local artisans of rightful recognition and credit for their work, who have preserved and practised this traditional art form for nearly 800 years," states the PIL filed by six advocates led by Ganesh Hingmire, an intellectual property rights expert. According to their petition, Kolhapuri chappal is protected with a geographical indication (GI). On June 22, Prada held its Spring/Summer 2026 Men's collection unveiling toe ring sandals "reportedly priced at over Rs 1 lakh per pair". There was no mention that it was Indian-inspired design. "The infringement of the design of the Kolhapuri chappal by a luxurious fashion label is without the knowledge or consent of the GI application holder or the authorised users," it adds. You Can Also Check: Mumbai AQI | Weather in Mumbai | Bank Holidays in Mumbai | Public Holidays in Mumbai While Prada "privately accepted" its collection is "inspired by Indian artisans", this acknowledgement surfaced after widespread backlash on social media. This acknowledgement was not given to the "makers of Kolhapuri chappals, GI Registry, the govt or public at large". Prada has not issued a formal apology, and the statement appears to be a "merely superficial attempt to deflect criticism". The petition said misuse causes "dilution of the GI identity, erodes its distinctiveness and unjustly enriches the foreign brand, depriving the artisans of the right economic and reputational benefits". The PIL says: "The handicraft is the result of countless hours of meticulous labour by artisans." Thus, Prada's "unauthorised profit-oriented motive displaying sandals deceptively close to Kolhapuri chappal and inscribing the word 'PRADA' on the footwear directly undermines the livelihood and dignity of the traditional artisans and authorised users of GI". The petitioners lament that the artisan community is not financially equipped to initiate civil proceedings, does not receive adequate support from govt bodies, and lacks awareness of their community rights, leaving them vulnerable. They want "strong, decisive measures to address these violations and set an exemplary legal precedent that deters future acts of cultural misappropriation". They have prayed for restraint and a permanent injunction on Prada from "commercialising the use of so-called toe ring sandals, which is originally a GI-tagged product, Kolhapuri chappal", to direct Prada to issue a widely circulated public apology and pay compensation to artisans for "reputational and economic damages." The PIL will be heard in due course.
